Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xencor Inc (XNCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,230,763
  • Shares Outstanding, K 55,630
  • Annual Sales, $ 35,710 K
  • Annual Income, $ -48,930 K
  • 36-Month Beta 1.63
  • Price/Sales 62.46
  • Price/Cash Flow N/A
  • Price/Book 4.16

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.14 +14.11%
on 05/31/18
43.39 -7.58%
on 06/07/18
+3.86 (+10.65%)
since 05/22/18
3-Month
27.57 +45.45%
on 04/30/18
43.39 -7.58%
on 06/07/18
+9.78 (+32.26%)
since 03/22/18
52-Week
18.97 +111.39%
on 11/02/17
43.39 -7.58%
on 06/07/18
+17.90 (+80.63%)
since 06/22/17

Most Recent Stories

More News
Xencor Inc Shares Up 29.5% Since SmarTrend's Buy Recommendation (XNCR)

SmarTrend identified an Uptrend for Xencor Inc (NASDAQ:XNCR) on May 14th, 2018 at $32.16. In approximately 1 month, Xencor Inc has returned 29.47% as of today's recent price of $41.63.

XNCR : 40.10 (+0.43%)
Xencor Inc Has Returned 29.9% Since SmarTrend Recommendation (XNCR)

SmarTrend identified an Uptrend for Xencor Inc (NASDAQ:XNCR) on May 14th, 2018 at $32.16. In approximately 3 weeks, Xencor Inc has returned 29.87% as of today's recent price of $41.76.

XNCR : 40.10 (+0.43%)
Xencor to Present at Upcoming Investor Conferences

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today...

XNCR : 40.10 (+0.43%)
13.8% Return Seen to Date on SmarTrend Xencor Inc Call (XNCR)

SmarTrend identified an Uptrend for Xencor Inc (NASDAQ:XNCR) on May 14th, 2018 at $32.15. In approximately 2 weeks, Xencor Inc has returned 13.76% as of today's recent price of $36.58.

XNCR : 40.10 (+0.43%)
XNCR Crosses Above Average Analyst Target

In recent trading, shares of Xencor, Inc have crossed above the average analyst 12-month target price of $39.20, changing hands for $39.66/share. When a stock reaches the target an analyst has set, the...

XNCR : 40.10 (+0.43%)
Xencor Reports First Quarter 2018 Financial Results

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer, today...

XNCR : 40.10 (+0.43%)
Market Trends Toward New Normal in LRAD, Xencor, QuinStreet, Old Second, WesBanco, and Invitae -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LRAD Corporation (NASDAQ:LRAD),...

OSBC : 15.20 (-1.30%)
NVTA : 8.08 (+0.87%)
WSBC : 46.91 (-0.64%)
QNST : 13.73 (+1.63%)
LRAD : 2.56 (+1.19%)
XNCR : 40.10 (+0.43%)
Xencor to Present at Deutsche Bank 43rd Annual Health Care Conference

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today...

XNCR : 40.10 (+0.43%)
DB : 11.01 (+1.10%)
Xencor to Host First Quarter 2018 Financial Results Webcast and Conference Call on May 7, 2018

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced...

XNCR : 40.10 (+0.43%)
Xencor Presents Preclinical Data on XmAb®24306, Introduces XmAb® IL15 Bispecific Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced...

XNCR : 40.10 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade XNCR with:

Business Summary

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

See More

Key Turning Points

2nd Resistance Point 41.30
1st Resistance Point 40.70
Last Price 40.10
1st Support Level 39.26
2nd Support Level 38.42

See More

52-Week High 43.39
Last Price 40.10
Fibonacci 61.8% 34.06
Fibonacci 50% 31.18
Fibonacci 38.2% 28.30
52-Week Low 18.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar